Australia's most trusted
source of pharma news
Posted 23 November 2021 AM
The TGA has granted provisional determination to a sixth Covid vaccine for adults, produced by Taiwanese company Medigen Vaccine Biologics.
The provisional determination was given to Grand Pacific CRO as the Australian sponsor, a company which conducts clinical trials in the Asia-Pacific region. Medigen produces vaccines for dengue and enterovirus, as well as biosimilars.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.